CHMP work plan 2026
CHMP work plan 2026
CHMP work plan 2026
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): GalliaPharm, gallium (68Ga) chloride,germanium (68Ge) chloride, Date of authorisation: 01/08/2024, Revision: 1, Status: Authorised
Training module EV-M8 - Considerations on the international transfer of personal (health) data in ICSRs -SUSARs originating in the EU
Training module EV-M8 - Considerations on the international transfer of personal (health) data in ICSRs -SUSARs originating in the EU
Training module EV-M8 - Considerations on the international transfer of personal (health) data in ICSRs -SUSARs originating in the EU
Frequently asked questions on the European Shortages Monitoring Platform (ESMP)
COMP work plan 2026
Minutes – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 17 December 2025
15th industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 4 December 2025, 12:30 (CET) to 4 December 2025, 17:30 (CET)